MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
825.78%
Quick Ratio
823.93%
Cash Ratio
151.97%
Debt to Asset Ratio
74.57%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Deposits and other assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Royalty purchase agreement
    • Others
Balance Sheets
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
20,472
34,690
42,012
18,749
Marketable securities
89,491
71,822
53,808
15,175
Accounts receivable, net
51
95
52
83
Inventory
250
310
365
185
Prepaid expenses and other current assets
977
994
1,531
1,690
Total current assets
111,241
107,911
97,768
35,882
Property and equipment, net
2,045
1,715
1,595
1,366
Right-of-use assets
1,171
1,496
1,653
1,806
Strategic investments
-
2,495
2,495
2,495
Deposits and other assets
1,243
1,240
1,296
1,276
Total assets
115,700
114,857
104,807
42,825
Deferred revenue, current portion
-
-
4,649
4,461
Accounts payable
6,132
6,095
8,473
5,308
Accrued expenses and other liabilities
6,531
9,890
6,837
6,650
Operating lease liability, current portion
808
751
696
642
Total current liabilities
13,471
16,736
20,655
17,061
Deferred revenue, less current portion
-
-
8,659
9,568
Royalty purchase agreement
34,593
16,482
16,167
-
Note payable
20,442
-
-
-
Loans payable
14,397
14,268
14,204
14,384
Derivative liability
2,460
2,749
-
-
Operating lease liability, less current portion
520
936
1,135
1,328
Other long-term liabilities
397
308
248
189
Total liabilities
86,280
51,479
61,068
42,530
Series a preferred stock, 0.0001 par value per share 200,000 issued and outstanding at june 30, 2026 and december 31, 2025 aggregate liquidation preference of 20,000
10,097
9,808
-
-
Common stock, 0.0001 par value per share 340,000,000 shares authorized 60,105,049 and 57,032,963 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
6
6
6
4
Additional paid-in capital
426,423
416,083
412,512
348,271
Accumulated other comprehensive (loss) income
-81
60
45
16
Accumulated deficit
-407,025
-362,579
-368,824
-347,996
Total stockholders' equity
19,323
53,570
43,739
295
Total liabilities, series a preferred stock and stockholders' equity
115,700
114,857
104,807
42,825
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$89,491K (489.73%↑ Y/Y)Cash and cashequivalents$20,472K (9.19%↑ Y/Y)Prepaid expenses andother current assets$977K (-42.19%↓ Y/Y)Inventory$250K (35.14%↑ Y/Y)Accounts receivable, net$51K (-38.55%↓ Y/Y)Total current assets$111,241K (210.02%↑ Y/Y)Property and equipment,net$2,045K (49.71%↑ Y/Y)Deposits and other assets$1,243K (-2.59%↓ Y/Y)Right-of-use assets$1,171K (-35.16%↓ Y/Y)Total assets$115,700K (170.17%↑ Y/Y)Total liabilities,series a preferred...$115,700K (170.17%↑ Y/Y)Total liabilities$86,280K (102.87%↑ Y/Y)Total stockholders'equity$19,323K (6450.17%↑ Y/Y)Series a preferredstock, 0.0001 par value...$10,097K Accumulated deficit-$407,025K (-16.96%↓ Y/Y)Accumulated othercomprehensive (loss) income-$81K (-606.25%↓ Y/Y)Royalty purchaseagreement$34,593K Note payable$20,442K Loans payable$14,397K (0.09%↑ Y/Y)Total currentliabilities$13,471K (-21.04%↓ Y/Y)Derivative liability$2,460K Operating leaseliability, less current...$520K (-60.84%↓ Y/Y)Other long-termliabilities$397K (110.05%↑ Y/Y)Additional paid-in capital$426,423K (22.44%↑ Y/Y)Common stock, 0.0001par value per share...$6K (50.00%↑ Y/Y)Accrued expenses andother liabilities$6,531K (-1.79%↓ Y/Y)Accounts payable$6,132K (15.52%↑ Y/Y)Operating leaseliability, current portion$808K (25.86%↑ Y/Y)

Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings, Inc. (OBIO)